Journal article · 2025 · Open access
Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline
CA A Cancer Journal for Clinicians, 76(1), e70041 · Published 4 December 2025 · DOI 10.3322/caac.70041
In brief
“Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline” is a 2025 journal article by Rebecca B. Perkins and 15 co-authors, published in CA A Cancer Journal for Clinicians. OpenAlex counts 56 citations as of 17 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at CA A Cancer Journal for Clinicians.
- Citations
- 56
- Most cited in
- 2026 (53)
- Field-weighted impact
- 24.05
- References
- 54
- Authors
- 16
Abstract
This update expands the 2020 American Cancer Society (ACS) cervical cancer screening guideline for average-risk women and individuals with a cervix who are at average risk, to include self-collection for human papillomavirus (HPV) testing and revised guidance for exiting cervical cancer screening. Self-collected vaginal specimens, a method of primary HPV testing, align with the ACS cervical cancer screening guideline. When clinician-collected cervical specimens are used for HPV testing, repeat screening is recommended every 5 years for those with a negative test. For self-collected vaginal specimens, the ACS endorses the following recommendations of the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee (of which it is a member): (1) primary HPV screening using clinician-collected cervical specimens is preferred, and self-collected vaginal specimens are acceptable for average-risk individuals aged 25-65 years; and (2) repeat testing in 3 years is recommended after a negative result on a self-collected HPV screening test. These recommendations apply only to combinations of collection devices and HPV assays approved by the US Food and Drug Administration for HPV testing in a clinical setting or at home. The rationale notes that the use of self-collected vaginal specimens can overcome barriers to screening for many patients, but most patients who test HPV-positive will require extra follow-up steps, and data on long-term, real-world effectiveness are limited. For certain high-risk individuals, clinician-collected samples are still recommended. Furthermore, in response to high rates of cervical cancer among individuals older than 65 years and with poor implementation of current exiting screening criteria, ACS has amended the 2020 guideline to recommend HPV testing at ages 60 and 65 years, with the last HPV test at an age no younger than 65 years as a requisite to exiting screening. The revised recommendation states: To qualify for discontinuation of screening, the ACS recommends an average-risk woman or an individual with a cervix at average risk have negative primary HPV tests (preferred) or negative co-testing using HPV tests and cytology (acceptable) at ages 60 and 65 years. If primary HPV tests or co-testing are not available, three consecutive negative cytology (Papanicolaou) tests at the recommended screening interval with the last test at age 65 years are acceptable. If self-collected vaginal specimens are used for HPV testing, the 3-year testing interval should be followed. Additional screening exit stipulations relate to women at higher risk because of prior abnormal test results or current immune suppression.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Perkins, R. B., Wolf, A. M. D., Church, T. R., Elkin, E. B., Skates, S. J., Etzioni, R., Guerra, C. E., Herzig, A. H., Hoffman, R. M., Oeffinger, K. C., Raoof, S., Shih, Y. T., Walter, L. C., Zeigler-Johnson, C. M., Manassaram‐Baptiste, D., & Smith, R. A. (2025). Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA A Cancer Journal for Clinicians, 76(1), e70041. https://doi.org/10.3322/caac.70041
MLA 9
Perkins, Rebecca B., et al. “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.” CA A Cancer Journal for Clinicians, vol. 76, no. 1, 2025, p. e70041. https://doi.org/10.3322/caac.70041.
Chicago
Perkins, Rebecca B., Andrew M. D. Wolf, Timothy R. Church, Elena B. Elkin, Steven J. Skates, Ruth Etzioni, Carmen E. Guerra, et al. 2025. “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.” CA A Cancer Journal for Clinicians 76 (1): e70041. https://doi.org/10.3322/caac.70041.
Harvard
Perkins, R. B. et al. (2025) ‘Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline’, CA A Cancer Journal for Clinicians, 76(1), p. e70041. doi:10.3322/caac.70041.
IEEE
R. B. Perkins et al., “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline,” CA A Cancer Journal for Clinicians, vol. 76, no. 1, p. e70041, 2025, doi: 10.3322/caac.70041.
BibTeX
@article{perkins2025self,
title = {{Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline}},
author = {Perkins, Rebecca B. and Wolf, Andrew M. D. and Church, Timothy R. and Elkin, Elena B. and Skates, Steven J. and Etzioni, Ruth and Guerra, Carmen E. and Herzig, Abbe H. and Hoffman, Richard M. and Oeffinger, Kevin Charles and Raoof, Sana and Shih, Ya‐Chen Tina and Walter, Louise Christie and Zeigler-Johnson, Charnita M and Manassaram‐Baptiste, Deana and Smith, Robert Allen},
journal = {CA A Cancer Journal for Clinicians},
year = {2025},
volume = {76},
number = {1},
pages = {e70041},
doi = {10.3322/caac.70041},
url = {https://doi.org/10.3322/caac.70041}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 1 | |
| 2025 | 1 | |
| 2026 | 53 |
Its field-weighted citation impact is 24.05: it has been cited 24.05 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- cervical cancer screening
- HPV testing
- primary HPV testing
- co-testing
- Pap smear
- older women
- immunosuppression
- high-risk individuals
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Perkins, R. B., Wolf, A. M. D., Church, T. R., Elkin, E. B., Skates, S. J., Etzioni, R., Guerra, C. E., Herzig, A. H., Hoffman, R. M., Oeffinger, K. C., Raoof, S., Shih, Y. T., Walter, L. C., Zeigler-Johnson, C. M., Manassaram‐Baptiste, D., & Smith, R. A. (2025). Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA A Cancer Journal for Clinicians, 76(1), e70041. https://doi.org/10.3322/caac.70041
How many times has this paper been cited?
56 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at CA A Cancer Journal for Clinicians: sign in and open the PDF from this page.
Who wrote this paper?
Rebecca B. Perkins, Andrew M. D. Wolf, Timothy R. Church, Elena B. Elkin, Steven J. Skates, Ruth Etzioni, Carmen E. Guerra, Abbe H. Herzig, Richard M. Hoffman, Kevin Charles Oeffinger, Sana Raoof, Ya‐Chen Tina Shih and 4 more.
What is the DOI of this paper?
10.3322/caac.70041, permanently at https://doi.org/10.3322/caac.70041. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.